Skip to main content
  • EN
  • FI
  • SV
Login

Main navigation

  • About FinnGen
    • Summary & Goals
      • Goals
      • FinnGen 1-2
      • FinnGen 3 (2023-2027)
    • Consortium
      • Partners
      • Funding
      • Governance
      • Steering Committee Members
      • Scientific Committee Members
      • Teams
      • Collaboration
    • Impact
      • National Impact
      • National Research Network
      • Open Science
      • Research Highlights
    • Why Finland?
      • Biobank Network
      • Legislative Review
      • National Registries
      • Population Genetic History
      • Industry partners
    • Mediabank
  • For Researchers
    • Research Activities
      • Core Analyses
      • Disease Task Forces
      • Expansion Areas
      • Global Initiatives
    • Cohort and Data
      • Register Data
      • Basic Characteristics
      • Clinical Endpoints
      • Genetic Data
      • Laboratory Values
      • Other Phenotype Data
      • Recruitment
      • Other Biological Data
      • Data Available
    • Accessing Data, Results & Tools
      • Access results
      • Computing environment
      • How we collaborate
      • Partner researchers
      • Public data releases
      • Tools
    • Publications
    • Researcher FAQ
  • For Participants
    • Participation
      • Study Participants
      • Biobanks' Role in FinnGen
      • Biobank Contact Information
      • Recall Studies
      • Questions and answers
    • Data Protection and Security
      • Data Protection
      • Data Security
      • Sample & Data Flow
      • Data Protection Statement
    • Significance
      • Videos
  • News
  • EN
  • FI
  • SV

Links

  • PheWeb
  • Risteys
  • Meta-analysis Pheweb (FG-MVP-UKBB)
  • FinnGen handbook
  • Meta-analysis Pheweb (FG-UKBB)
  • Coding variant browser
  • Endpoint Browser
  • FinnGen GITHUB
  • LAVAA volcano plot
  • Multiple Manhattan Plot
  • Variant Cluster Corrector
  • Variant Cluster Call Corrector
Breadcrumb
  1. Home

Potential drug targets for asthma identified through mendelian randomization analysis

Submitted by Frida Mäkelä on Thu, 01/16/2025 - 16:15
  • Read more about Potential drug targets for asthma identified through mendelian randomization analysis

Genetic insight into dissecting the immunophenotypes and inflammatory profiles in the pathogenesis of Sjogren syndrome

Submitted by Frida Mäkelä on Thu, 01/16/2025 - 16:11
  • Read more about Genetic insight into dissecting the immunophenotypes and inflammatory profiles in the pathogenesis of Sjogren syndrome

Is there a causal association between temporomandibular disorders and COVID-19 risk? A genetic instrumental variables analysis

Submitted by Frida Mäkelä on Thu, 01/16/2025 - 15:59
  • Read more about Is there a causal association between temporomandibular disorders and COVID-19 risk? A genetic instrumental variables analysis

Separating the Effects of Early-Life and Adult Body Size on Chronic Kidney Disease Risk: A Mendelian Randomization Study

Submitted by Frida Mäkelä on Thu, 01/16/2025 - 15:55
  • Read more about Separating the Effects of Early-Life and Adult Body Size on Chronic Kidney Disease Risk: A Mendelian Randomization Study

Genetic causality between insomnia and specific orthopedic conditions: Insights from a two-sample Mendelian randomization study

Submitted by Frida Mäkelä on Thu, 01/16/2025 - 15:49
  • Read more about Genetic causality between insomnia and specific orthopedic conditions: Insights from a two-sample Mendelian randomization study

Inflammatory bowel disease increases the risk of pancreatitis: a two-sample bidirectional Mendelian randomization analysis

Submitted by Frida Mäkelä on Thu, 01/16/2025 - 15:39
  • Read more about Inflammatory bowel disease increases the risk of pancreatitis: a two-sample bidirectional Mendelian randomization analysis

Association of antihypertensive drug target genes with alzheimer's disease: a mendelian randomization study

Submitted by Frida Mäkelä on Thu, 01/16/2025 - 15:21
  • Read more about Association of antihypertensive drug target genes with alzheimer's disease: a mendelian randomization study

Evaluating the causal effect of using glucagon-like peptide-1 receptor agonists on the risk of autoimmune diseases

Submitted by Frida Mäkelä on Thu, 01/16/2025 - 15:12
  • Read more about Evaluating the causal effect of using glucagon-like peptide-1 receptor agonists on the risk of autoimmune diseases

Causal relationship between immune cells and heart failure: A Mendelian randomization study

Submitted by Frida Mäkelä on Thu, 01/16/2025 - 15:08
  • Read more about Causal relationship between immune cells and heart failure: A Mendelian randomization study

Immune Cells and Intracerebral Hemorrhage: A Causal Investigation Through Mendelian Randomization

Submitted by Frida Mäkelä on Thu, 01/16/2025 - 15:03
  • Read more about Immune Cells and Intracerebral Hemorrhage: A Causal Investigation Through Mendelian Randomization

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 181
  • Page 182
  • Page 183
  • Page 184
  • Current page 185
  • Page 186
  • Page 187
  • Page 188
  • Page 189
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Contact us

Contact person
finngen-info@helsinki.fi
Follow us on Bluesky
@finngen.bsky.social

Lead organisations

The University of Helsinki is the organization responsible for the FinnGen research project. The Finnish consortium partners include all Finnish public biobanks and their background organisations, so the project covers the whole of Finland. All partners are listed on this page.

About the website

Accessibility statement